BlackRock Group’s Evolent Health EVH Stock Holding History

BlackRock Group’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$154K	Buy	10,369 +3,099	+43%	+$61.1K	﹤0.01%	2734
2016 Q3	$178K	Buy	7,270 +4,857	+201%	+$114K	﹤0.01%	2666
2016 Q2	$46K	Hold	2,413	–	–	﹤0.01%	2930
2016 Q1	$25K	Buy	+2,413	New	+$24.9K	﹤0.01%	3013
2015 Q4	–	Sell	-72,534	Closed	-$1.16M	–	3020
2015 Q3	$1.16M	Sell	72,534 -135,775	-65%	-$2.65M	﹤0.01%	1797
2015 Q2	$4.06M	Buy	+208,309	New	+$3.88M	﹤0.01%	1204

Other funds holding EVH

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

BlackRock Group's EVH Position: Q4 2016 in Review

BlackRock Group increased its Evolent Health (EVH) stake by 43% in Q4 2016, buying an estimated $61.1K and bringing the position to 10,369 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #2734.

BlackRock Group first reported a position in EVH in Q2 2015 and has held it in 6 quarters since. The position peaked at $4.06M in Q2 2015. 118 funds tracked by Wall St. Rank hold EVH as of Q4 2016.

BlackRock Group held 10,369 shares of Evolent Health worth $154K as of Q4 2016.
BlackRock Group bought 3,099 Evolent Health shares in Q4 2016, an estimated $61.1K.
Evolent Health made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2734 holding.
BlackRock Group first reported a position in Evolent Health in Q2 2015 and has held it in 6 quarters since.
BlackRock Group's Evolent Health position peaked at $4.06M in Q2 2015.
118 funds tracked by Wall St. Rank held Evolent Health as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.